The Seattle Genetics Medical Affairs Fellowship is a one-year, experiential program at Seattle Genetics, Inc. based in Bothell, WA. The purpose of this program is to prepare PharmD fellows for career opportunities in pharmaceutical Medical Affairs by providing in-depth biopharmaceutical industry experiences and enhancing clinical knowledge.
The fellow will build Medical Affairs expertise and expand their clinical knowledge through active participation on the Medical Affairs team. During the fellowship year, the fellow will have the opportunity to achieve the following objectives: obtain an understanding of the role of Medical Affairs in the biopharmaceutical industry; develop clinical data analysis, interpretation, and communication skills; gain the ability to recognize unmet patient needs and render clinical insight for application to strategic product plans, and develop industry-appropriate professional skills to promote the role of PharmDs in the pharmaceutical industry. The fellow will have opportunities to gain experience through rotations with the Medical Information, Medical Communications, Clinical Value and Outcomes, Scientific Alliances, Medical Education, Medical Director, and Medical Science Liaison teams. The fellow will also interact with key cross-functional groups within Seattle Genetics, including Commercial, Regulatory, and Clinical Development.
The fellow will support ADCETRIS® (brentuximab vedotin), a novel, antibody-drug conjugate (ADC) directed to the CD30 surface antigen on cells using Seattle Genetics' proprietary ADC technology. ADCETRIS® (brentuximab vedotin) is approved for the treatment of two types of lymphoma in more than 71 countries, including the U.S., Canada, Japan and members of the European Union. The fellow will also provide support for Seattle Genetics’ pipeline programs.
Develop skills in a broad set of Medical Affairs-related areas and their role within the pharmaceutical industry
Congress planning and project management to support Medical Affairs at large national meetings, including authoring communications materials and digital content, developing graphics, and working with vendors
Use clinical expertise and insights gathered to inform projects and initiatives in Medical Affairs and other departments
Cross-functional collaboration within Seattle Genetics, as well as interface with external stakeholders that may include healthcare professionals, payers, corporate partners, and others
Research, create, update and review medical information resources and materials to provide fair and scientifically balanced responses to medical inquiries for Seattle Genetics products
Assist with the review of investigator sponsored research proposals
Provide input in the development and review of medical publications, ensuring scientifically accurate manuscripts and materials
Coordinate and participate in the medical review of scientific and promotional materials for external publication and presentation, as well as internal training
Assist Medical Science Liaisons in supporting investigator-led studies, communicating with health care professionals, and supporting research activities
Create and execute longitudinal projects, with publication and/or presentation opportunities
Give regular presentations of Medical Affairs-related topics for both internal and external audiences
Travel may include, but is not limited to, the annual ASCO/ ASH meetings and ASHP Midyear
A Doctor of Pharmacy (PharmD) degree from an ACPE accredited institution
Relevant Internship or Clerkship experiences
Prior clinical or industry experience is preferred
Prior oncology experience is preferred
Completion of a PGY1 or PGY2 pharmacy residency is desirable
Evidence of appropriate analytical, planning and organizational skills
Basic knowledge of the pharmaceutical industry including Product Development, Manufacturing, Regulatory, Medical Affairs, and Commercial operations
Possess good communication skills, including oral, written and presentation
Self-motivated, energetic, able to work and learn independently
Ability to thrive in a fast-paced, dynamic environment
Seattle Genetics is an equal opportunity employer. All qualified applications will receive consideration for employment without regard to race, age, gender identity, sexual orientation, color, religion, sex, marital status, national origin, protected veteran status, disability status, or any other status protected by federal, state, or local law.
Application deadline is Friday, November 30th, 2018. No references necessary until final onsite interview at Seattle Genetics.
About Seattle Genetics
Seattle Genetics is an emerging multi-product, global biotechnology company and the largest based in the Pacific Northwest. We develop and commercialize transformative therapies targeting cancer to make a meaningful difference in people’s lives. ADCETRIS® (brentuximab vedotin) utilizes the company’s industry-leading antibody-drug conjugate (ADC) technology and is approved for the treatment of multiple CD30-expressing lymphomas.
Beyond ADCETRIS, the company has established a pipeline of novel targeted therapies at various stages of clinical testing, including three in ongoing or planned pivotal trials for solid tumors. Enfortumab vedotin for metastatic urothelial cancer and tisotumab vedotin for metastatic cervical cancer utilize our proprietary ADC technology. Tucatinib, a small molecule tyrosine kinase inhibitor, is in a pivotal trial for HER2-positive metastatic breast cancer. In addition, we are leveraging our expertise in empowered antibodies to build a portfolio of proprietary immuno-oncology agents in clinical trials targeting hematologic malignancies and solid tumors.
With multiple global product opportunities, significant research into advancing ADC technology and an emerging complementary immuno-oncology technology, we are positioned to transform cancer therapy.